ProBio
Taipei, TW
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-29
78.1
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (2)
✓ EMA GMP (9)
○ MHRA GMP
Quick Facts: ProBio
- Signal Score
- 78.1/100 (as of 2026-04-29)
- Quality Compliance
- 100.0/100 — No FDA inspection records found for this manufacturer
- Headquarters
- Taipei, TW
- Modalities
- mRNA, Biologics
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About ProBio
Pure-play CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Source: FDA Data Dashboard
No FDA inspection records found for this manufacturer · Quality score requires FDA inspection data
FDA InspectionsNo US records on file
EMA GMP Certificates9 on record
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesmRNA, Biologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
58.0
1 manufacturing site: Taipei, TW
Modalities: mRNA, Biologics
Capacity assessment: 58.0/100
Sites: Taipei, TW
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
Recent Press2 articles
1 manufacturing site: Taipei, TW
Modalities: mRNA, Biologics
Capacity assessment: 58.0/100
EMA GMP Compliance 9 certificates
2025-11
2024-09
2024-09
2024-01
2023-12
2022-03
2020-01
2020-01
2019-07
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| BE/GMP/2025/190 | ReprobiolAlternative Name:Reprobiol S.R.L. | Belgium | 2025-11-05 | COMPLIANT |
| IT-API/112/H/2025 | Probiotical S.p.A. | Italy | 2024-09-20 | COMPLIANT |
| IT/169/H/2025 | Probiotical S.p.A. | Italy | 2024-09-20 | COMPLIANT |
| ISF.405.32.2024.IP.1 WTC/0465_01_01/50 | Suprobion Sp. z o.o. sp.k. | Poland | 2024-01-24 | COMPLIANT |
| BE/GMP/2023/133 | Reprobiol | Belgium | 2023-12-20 | COMPLIANT |
| DK H 10000541 | Deerland Probiotics & Enzymes A/S | Denmark | 2022-03-31 | COMPLIANT |
| DK IMP 00133120 | Deerland Probiotics & Enzymes A/S | Denmark | 2020-01-23 | COMPLIANT |
| DK H 00133120 | Deerland Probiotics & Enzymes A/S | Denmark | 2020-01-23 | COMPLIANT |
| IT-API/9/H/2020 | PROBIOTICAL S.P.A. | Italy | 2019-07-19 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved May 20, 2026
Recent News 2 articles
ProBio Tackles Gene Therapy Bottleneck with New Rapid Test - BriefGlance
ProBio Tackles Gene Therapy Bottleneck with New Rapid Test BriefGlance
ProBio De-Risks Cell & Gene Therapy with New Packaging Test - PR Newswire
ProBio De-Risks Cell & Gene Therapy with New Packaging Test PR Newswire
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 91.5
Biologics, mRNA
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 82.5
mRNA, Oligonucleotide, Biologics
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.8
mRNA, Biologics, Cell Therapy
Wacker Biotech
Jena, DE · Amsterdam, NL · San Diego, CA
Signal Score: 81.6
mRNA, Plasmid, Biologics
Evonik Health Care
Birmingham, AL · Vancouver, BC
Signal Score: 81.5
mRNA, Biologics